Financial News Feed

Stronger Sell Today ACRS ranks #4141 as SELL CANDIDATE. Weaker Sell
Today ACRS ranks #4141 as SELL CANDIDATE.

ACRS stock Aclaris Therapeutics

ACRS stock
Aclaris Therapeutics

Aclaris Therapeutics Inc. (NASDAQ:ACRS) and Agenus Inc. (NASDAQ:AGEN) are two firms in the Biotechnology that compete against each other. Below is a comparison of their profitability, analyst recommen...

Read more

We are contrasting Aclaris Therapeutics Inc. (NASDAQ:ACRS) and its peers on their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. They are Bio...

Read more

As Biotechnology businesses, Aclaris Therapeutics Inc. (NASDAQ:ACRS) and Syros Pharmaceuticals Inc. (NASDAQ:SYRS), are affected by contrast. This especially...

Read more

Aclaris Therapeutics, Inc. (ACRS) formed triangle with $6.30 target or 6.00% above today's $5.94 share price. Aclaris Therapeutics, Inc. (ACRS) has $245.14M Sentiment for TTM Technologies Inc (TTMI)TT...

Read more

As Biotechnology businesses, Aclaris Therapeutics Inc. (NASDAQ:ACRS) and Alector Inc. (NASDAQ:ALEC), are affected by contrast. This especially applies to their...

Read more

As Biotechnology businesses, PolarityTE Inc. (NASDAQ:PTE) and Aclaris Therapeutics Inc. (NASDAQ:ACRS), are affected by contrast. This especially applies to...

Read more

Cantor Fitzgerald restated their buy rating on shares of Aclaris Therapeutics (NASDAQ:ACRS) in a research report report published on Friday morning. They currently have a $50.00 price objective on the...

Read more

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) shares have moved -12.39% on the week. The stock closed the most recent session at $5.94 after seeing 641692 shares trade hands. This represents a change of -2...

Read more

Taking a look at some key metrics and ratios for ÅF AB (publ) (OM:AF B), we note that the ROA or Return on Assets stands at 0.074706. Return on Assets shows how many dollars of earnings result from e...

Read more

Since Aclaris Therapeutics Inc. (NASDAQ:ACRS) and Acorda Therapeutics Inc. (NASDAQ:ACOR) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the ...

Read more

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) closed at $6.27 after the last trading day, drawing interest from investors and traders. The stock trades on NSDQ in the Medical sector and Medical – Drugs i...

Read more

As Biotechnology companies, Magenta Therapeutics Inc. (NASDAQ:MGTA) and Aclaris Therapeutics Inc. (NASDAQ:ACRS) are our subject to contrast. And more specifically their institutional ownership, analys...

Read more

Both Achieve Life Sciences Inc. (NASDAQ:ACHV) and Aclaris Therapeutics Inc. (NASDAQ:ACRS) are Biotechnology companies, competing one another. We will contrast...

Read more

Here we will take a look into some valuation metrics for Aclaris Therapeutics, Inc. NasdaqGS:ACRS shares. Price-To-Cash-Flow-Ratio is a term that indicates the degree of cash flow valuation of the ent...

Read more

Checking in on shares of Aclaris Therapts (ACRS), we can see that the current opinion signal on the stock for today’s session is 32% Sell. Looking back at the last month, the opinion signal reads 80...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank